On the whole, I've liked Alfa Laval (OTCPK:ALFVY)
more than the Street, and that has worked out okay, with the stock more
or less performing in line with the S&P and beating its industrial
peer group. Now, though, the company has made a controversial decision
to pay a high premium to buy its way into the valve market
- a decision that, in the short term at least, will only magnify
concerns about the company's exposure to weak end-markets like oil/gas
and petrochemicals.
I can understand the long-term
argument for acquiring Neles, and I'm certainly not going to ignore the
idea that the premium multiple Alfa is offering is inflated by weak
current conditions. Moreover, if investors are constantly advised to try
to buy into weakness, doesn't the same apply to companies? All of that
said, I think there were better options for Alfa, and I think this is a
deal that could weigh on sentiment until management can show real
deliverables on the deal.
Click here to continue:
Alfa Laval's Proposed Acquisition Adds Capital Deployment To The List Of Investor Worries
No comments:
Post a Comment